Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-1596

Requesting Plavix be included in the eMeasure 71 Value Set

XMLWordPrintable

    • Icon: Value Sets Value Sets
    • Resolution: Answered
    • Icon: Minor Minor
    • Measure, ValueSet
    • None
    • Hide
      Acute ischemic stroke patients with atrial fibrillation need a more potent blood thinner than Plavix, which is why it is not included in the value set for CMS71. While Plavix is the most commonly prescribed antithrombotic medication at discharge, in addition to aspirin, ischemic stroke patients with atrial fibrillation should be discharged on warfarin, a NOAC, or less frequently other anticoagulants.
      Show
      Acute ischemic stroke patients with atrial fibrillation need a more potent blood thinner than Plavix, which is why it is not included in the value set for CMS71. While Plavix is the most commonly prescribed antithrombotic medication at discharge, in addition to aspirin, ischemic stroke patients with atrial fibrillation should be discharged on warfarin, a NOAC, or less frequently other anticoagulants.
    • Patients dicharged on Plavix (clopidogril) are not included into eMeasure 71. Patients are being discharged more frequently on Plavix.

      Currently Plavix (clopidogril) is not included in the Value Set for eMeasure 71. Due to the increased occurrences of patients being discharged home with Plavix, it is requested that this medication be placed in the value set for this measure.

            JLeflore Joelencia Leflore
            bnvilla Brooke Villarreal
            Votes:
            0 Vote for this issue
            Watchers:
            2 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: